Ralliant (NYSE:RAL) Sets New 1-Year High – What’s Next?

Ralliant Corporation (NYSE:RAL) hit a new 52-week high on Wednesday . The company traded as high as $70.99 and last traded at $71.4910, with a volume of 58575 shares. The stock had previously closed at $69.22.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on RAL shares. Oppenheimer upped their target price on shares of Ralliant from $50.00 to $65.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Truist Financial restated a “buy” rating and issued a $68.00 price objective (up from $53.00) on shares of Ralliant in a research report on Wednesday, May 13th. Morgan Stanley upped their price objective on Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a report on Tuesday. Zacks Research upgraded Ralliant from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Finally, Evercore assumed coverage on Ralliant in a research note on Tuesday, June 9th. They issued an “outperform” rating and a $80.00 target price for the company. Seven research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $69.00.

Ralliant Trading Up 1.9%

The business has a 50 day moving average of $57.60 and a 200 day moving average of $51.10. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.61 and a quick ratio of 1.05. The firm has a market capitalization of $8.24 billion and a price-to-earnings ratio of -6.73.

Ralliant (NYSE:RAL) last issued its earnings results on Tuesday, May 12th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.08. The firm had revenue of $534.60 million for the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.The business’s quarterly revenue was up 11.0% compared to the same quarter last year. Ralliant has set its FY 2026 guidance at 2.530-2.690 EPS and its Q2 2026 guidance at 0.580-0.640 EPS. As a group, research analysts predict that Ralliant Corporation will post 2.64 earnings per share for the current fiscal year.

Ralliant Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 8th were given a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant’s dividend payout ratio (DPR) is currently -1.83%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. Cetera Investment Advisers acquired a new stake in Ralliant in the second quarter worth $700,000. Russell Investments Group Ltd. bought a new stake in shares of Ralliant in the 2nd quarter valued at $1,465,000. EverSource Wealth Advisors LLC acquired a new stake in Ralliant during the 2nd quarter worth $39,000. First Trust Advisors LP acquired a new stake in Ralliant during the 2nd quarter worth $2,013,000. Finally, Federated Hermes Inc. bought a new position in Ralliant during the second quarter worth about $326,000.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.